Tech Company M&A Transactions
CyVek Acquisition
CyVek, operating out of Wallingford, was acquired by Bio-Techne. Bio-Techne said the transaction price was $95 million.
Transaction Overview
Company Name
Acquired By
Announced On
11/4/2014
Transaction Type
M&A
Amount
$95,000,000
M&A Terms
Bio-Techne Corporation (NASDAQ: TECH) announced today that it has agreed to acquire CyVek, Inc. (CyVek) for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 in excess of $100 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2 Barnes Industrial Road South
Wallingford, CT 06492
USA
Wallingford, CT 06492
USA
Phone
Website
Email Address
Overview
The objective of the CyVek technology is to provide a robust platform for multiplexed proteomics, particularly to serve the market needs of biomarker validation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Per Hellsund
Chief Technical Officer
Marty Putnam
VP - Bus. Development
Rajiv Pande
Browse more venture capital transactions:
Prev: 11/4/2014: Changelane venture capital transaction
Next: 11/4/2014: Imbue venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs